valueequityanalysis.com

Independent, business-by-business valuations built from company filings — owner earnings, a ten-year outlook, and a bear / base / bull range. Search a ticker to see our estimate of what the business is worth.

Not investment advice. We are not registered investment advisers, and the people behind this site may hold or trade positions in companies analyzed here. Full disclosures.

SENSIENT TECHNOLOGIES CORP (SXT) stock intrinsic value fair value estimate & owner earnings analysis

Margin of safety$25.00 ComplexityAverage Updated
$26.97 $57.45
bear $26.97 base $45.25 bull $57.45 margin of safety $25.00 market price* $133.74
Sensient Technologies, based in Milwaukee, makes colors, flavors and specialty ingredients that other companies build into their products. Its Color Group ($680 million of 2025 revenue) is the world's largest maker of certified synthetic food colors and a major producer of natural colors, and also sells colors and excipients to cosmetics and pharmaceutical makers. Its Flavors & Extracts Group ($764 million) sells flavors, natural extracts and dehydrated vegetables, and the Asia Pacific Group ($168 million) sells both product lines across the Pacific Rim and India. Customers rarely switch an ingredient once it is formulated into a product, and the company has paid an uninterrupted quarterly dividend since 1962. How we measure earnings. We start from cash from operations, strip out the timing swings in inventories, receivables and payables, subtract stock compensation as a real cost, and subtract the capital spending needed to keep the plants running. On that basis earnings per share were $2.44 (2016), $3.06 (2017), $4.02 (2018), $2.88 (2019), $2.49 (2020), $2.85 (2021), $2.45 (2022), $1.98 (2023), $2.67 (2024) and $2.62 (2025). Two judgements matter. First, in 2017 and 2018 Sensient reported collections on receivables it had sold as investing rather than operating cash, which is why reported operating cash flow looks so weak in those years; removing working-capital swings neutralizes this. Second, our capital-spending rule treats only spending in line with sales growth as growth spending, so most of the heavy 2023 and 2025 outlays are charged as upkeep, even though the 2025 annual report says the extra borrowing that year mainly funded capacity for converting customers from synthetic to natural colors. That makes the recent figures conservative rather than generous. The starting level. We use 2020 through 2025, the period in which Sensient sold its inks (2020), yogurt fruit preparation (2020) and fragrance (2021) product lines and which spans the 2020 shutdown and the 2022-2023 period of raw-material inflation and customer destocking, so it covers a full cycle for today's business. 2020 and 2021 still include part-year results of the sold lines; dropping 2020 would raise the starting level slightly, so keeping it is the cautious choice. Earlier years describe a different mix of businesses, and 2018 was lifted by unusually high reported earnings. The median of 2020-2025 is about $2.55 per share after interest, or about $3.00 per share (about $128 million) before the roughly $25-30 million a year the company now pays its lenders. We value the business on that before-interest figure and then subtract the debt. Near-term path. In 2025 the before-interest figure fell 1.4% (from $3.35 to $3.31 per share) as natural-color capital spending rose. Our base case starts year one at $3.40, about 2.7% above 2025. The reason is in the June 2026 quarterly report: first-half 2026 revenue rose 11% and net earnings 33%, with Color Group revenue up 19% and its operating income up 31% on higher volume and prices, across two consecutive quarters. The FDA's revocation of Red No. 3 for food, effective in January 2027, is a legal change already locked in that pushes customers toward the natural colors Sensient makes. What we credited and left out. We credit growth of 1.5% a year after year one, below the roughly 1.7% a year per-share growth the business actually delivered from 2016 to 2025, a period that included the 2022-2023 downturn. We do not credit West Virginia's synthetic-dye ban, which is under a preliminary injunction, unenacted state proposals, voluntary pledges by large food companies, or management's 2026 outlook. After year ten we hold earnings flat rather than growing them, because the evidence that supports permanence (a century-old ingredient franchise embedded in customers' recipes) does not support continued growth. Debt. At June 30, 2026 Sensient owed about $764 million: senior notes of $35 million to $75 million each, maturing between November 2026 and November 2029 at fixed rates of 1.71% to 6.34%, a euro term loan of about $88 million, and a revolving credit facility. Most of this carries interest below what new long-term money would cost, so we reduce the debt figure by about $15 million to about $749 million, or $17.52 per share. Cash of about $31 million is treated as needed to run operations around the world. Interest of about $29 million a year is covered nearly five times by cash earnings before interest, so refinancing the 2026-2029 maturities is not a material risk in any of the cases. Bear case ($26.97 per share). Year one at $3.00 with no benefit from color conversion. Then a downturn as deep as 2022-2023, when per-share cash earnings before interest fell from $3.15 to $2.56 (about 19%) on raw-material inflation and customer destocking: $2.70 in year two and $2.45 in year three. A recovery to $2.75 by year five, after which the roughly $100 million North American synthetic food-color business shrinks without being fully replaced by natural colors, leaving earnings flat at $2.65 for good. The business is worth about $44.48 per share (about $1.90 billion); less $17.52 of debt leaves $26.97. Even at the trough, cash earnings are about three times the interest bill. Base case ($45.25 per share). $3.40 in year one, growing 1.5% a year to $3.89 in year ten, then flat. The business is worth about $62.77 per share (about $2.68 billion); less $17.52 of debt leaves $45.25. Bull case ($57.45 per share). Year one at $3.60, about the pace implied by first-half 2026 results. Capacity already built and under construction for natural colors fills as customers meet the 2027 Red No. 3 deadline, and capital spending falls back toward depreciation (about $61 million in 2025), roughly where it ran in 2021 and 2024, once the build-out is complete. That takes earnings to $4.20 by year four, then 2% a year to $4.73 in year ten, then flat. The business is worth about $74.97 per share (about $3.21 billion); less $17.52 of debt leaves $57.45. Margin-of-safety price. We are fairly confident in the earnings level: ten years of per-share owner earnings between about $2.00 and $3.10 in every year but 2018, no single customer the company considers significant to the whole, no country other than the United States above 10% of sales, and a product that is a small cost in customers' recipes but expensive for them to change. The worst plausible outcome is that the natural-color conversion stalls in court and in politics after Sensient has spent heavily on capacity, while its synthetic color business shrinks anyway and a food-industry slowdown arrives at the same time. The structure would survive that: the debt is moderate and spread over five years, the plants are hard assets, and no single customer or regulator decides the outcome. If we are wrong about the conversion and the downturn together, the shares are worth roughly the bear case value of about $27. The business pays $1.64 a year in dividends, and the price assumes a three-to-five-year holding period. The margin-of-safety price is $25: from that price, with the dividend and value moving toward the base case over about four years, the base case implies roughly 20% a year, and the bear case implies a modest positive return. Since our previous analysis. The previous figures were prepared on a different basis and are not comparable. What has changed in the business is that the natural-color conversion has started to show up in results: Color Group revenue up 19% in the first half of 2026 after the FDA's Red No. 3 decision and state actions in 2025. What would make this wrong. A ruling or policy reversal that halts the move away from synthetic colors after the capacity is built, a loss of share in natural colors to competitors such as Oterra, GNT or Givaudan, a sustained fall in food volumes, or capital spending that stays near 2025-2026 levels without earnings following.
Fiscal yearOwner's earningsMethodology
2025 $2.62 ▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$127.8M; dWC (sum of changes in operating assets and liabilities in cash-flow statement)=$(84.6)M; SBC=$13.9M; capex=$89.4M, growth capex=$2.5M (capex/revenue mean 2016-2025 4.58% x revenue change $54.9M), maintenance capex=$86.9M; OE=$111.6M; diluted shares=42.595M; OE/sh=$2.62. Reconciliation: NI $134.5M + D&A $61.1M + other non-cash $5.6M + deferred tax $(2.7)M - maint capex = $111.6M (0% gap). Source: 0001140361-26-005311 (FY2025 10-K).
2024 $2.67 ▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$157.2M; dWC (sum of changes in operating assets and liabilities in cash-flow statement)=$(20.6)M; SBC=$10.1M; capex=$59.2M, growth capex=$4.6M (capex/revenue mean 2016-2025 4.58% x revenue change $100.8M), maintenance capex=$54.6M; OE=$113.1M; diluted shares=42.396M; OE/sh=$2.67. Reconciliation: NI $124.7M + D&A $60.3M + other non-cash $1.3M + deferred tax $(18.6)M - maint capex = $113.1M (0% gap). Source: 0001140361-26-005311 (FY2025 10-K).
2023 $1.98 ▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$169.7M; dWC (sum of changes in operating assets and liabilities in cash-flow statement)=$(10.0)M; SBC=$8.9M; capex=$87.9M, growth capex=$0.9M (capex/revenue mean 2016-2025 4.58% x revenue change $19.4M), maintenance capex=$87.0M; OE=$83.8M; diluted shares=42.242M; OE/sh=$1.98. Reconciliation: NI $93.4M + D&A $57.8M + other non-cash $24.6M + deferred tax $(5.1)M - maint capex = $83.8M (0% gap). Source: 0001140361-26-005311 (FY2025 10-K).
2022 $2.45 ▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$12.1M; dWC (sum of changes in operating assets and liabilities in cash-flow statement)=$(184.2)M; SBC=$16.1M; capex=$79.3M, growth capex=$2.6M (capex/revenue mean 2016-2025 4.58% x revenue change $56.8M), maintenance capex=$76.7M; OE=$103.4M; diluted shares=42.213M; OE/sh=$2.45. Reconciliation: NI $140.9M + D&A $52.5M + other non-cash $(2.3)M + deferred tax $(11.0)M - maint capex = $103.4M (0% gap). Source: 0001140361-23-007579 (FY2022 10-K).
2021 $2.85 ▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$145.2M; dWC (sum of changes in operating assets and liabilities in cash-flow statement)=$(43.4)M; SBC=$9.6M; capex=$60.8M, growth capex=$2.2M (capex/revenue mean 2016-2025 4.58% x revenue change $48.3M), maintenance capex=$58.6M; OE=$120.5M; diluted shares=42.258M; OE/sh=$2.85. Reconciliation: NI $118.7M + D&A $52.1M + other non-cash $14.4M + deferred tax $(6.1)M - maint capex = $120.5M (0% gap). Source: 0001140361-23-007579 (FY2022 10-K).
2020 $2.49 ▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$218.8M; dWC (sum of changes in operating assets and liabilities in cash-flow statement)=$56.1M; SBC=$5.6M; capex=$52.2M, growth capex=$0.4M (capex/revenue mean 2016-2025 4.58% x revenue change $9.1M), maintenance capex=$51.7M; OE=$105.3M; diluted shares=42.346M; OE/sh=$2.49. Reconciliation: NI $109.5M + D&A $49.6M + other non-cash $6.7M + deferred tax $(8.7)M - maint capex = $105.3M (0% gap). Source: 0001140361-23-007579 (FY2022 10-K).
2019 $2.88 ▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$177.2M; dWC (sum of changes in operating assets and liabilities in cash-flow statement)=$16.9M; SBC=$(0.7)M; capex=$39.1M, growth capex=$0 (revenue declined $(63.9)M), maintenance capex=$39.1M; OE=$121.9M; diluted shares=42.294M; OE/sh=$2.88. Reconciliation: NI $82.0M + D&A $55.0M + other non-cash $43.3M + deferred tax $(19.3)M - maint capex = $121.9M (0% gap). Source: 0001140361-20-003752 (FY2019 10-K).
2018 $4.02 ▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$83.5M; dWC (sum of changes in operating assets and liabilities in cash-flow statement)=$(137.5)M; SBC=$0.5M; capex=$50.7M, growth capex=$1.1M (capex/revenue mean 2016-2025 4.58% x revenue change $24.6M), maintenance capex=$49.6M; OE=$170.9M; diluted shares=42.499M; OE/sh=$4.02. Reconciliation: NI $157.4M + D&A $53.2M + other non-cash $0.1M + deferred tax $9.8M - maint capex = $170.9M (0% gap). Source: 0001140361-20-003752 (FY2019 10-K). CFO and the receivables change reflect collections on sold receivables classified in investing activities (2017 $141.5M, 2018 $91.1M per FY2019 10-K); removing dWC neutralizes this classification.
2017 $3.06 ▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$36.3M; dWC (sum of changes in operating assets and liabilities in cash-flow statement)=$(160.8)M; SBC=$5.9M; capex=$56.3M, growth capex=$0 (revenue declined $(20.9)M), maintenance capex=$56.3M; OE=$134.9M; diluted shares=44.031M; OE/sh=$3.06. Reconciliation: NI $89.6M + D&A $48.5M + other non-cash $35.7M + deferred tax $17.4M - maint capex = $134.9M (0% gap). Source: 0001140361-20-003752 (FY2019 10-K). CFO and the receivables change reflect collections on sold receivables classified in investing activities (2017 $141.5M, 2018 $91.1M per FY2019 10-K); removing dWC neutralizes this classification.
2016 $2.44 ▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$183.6M; dWC (sum of changes in operating assets and liabilities in cash-flow statement)=$(14.3)M; SBC=$7.7M; capex=$81.2M, growth capex=$0.4M (capex/revenue mean 2016-2025 4.58% x revenue change $8.6M), maintenance capex=$80.8M; OE=$109.4M; diluted shares=44.843M; OE/sh=$2.44. Reconciliation: NI $126.3M + D&A $47.0M + other non-cash $6.5M + deferred tax $10.4M - maint capex = $109.4M (0% gap). Source: 0001140361-19-003673 (FY2018 10-K; 2016 as restated). 2016 revenue change measured on the as-originally-reported basis (2015 $1,412.5M vs 2016 $1,421.1M) because 2015 was not restated.

Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.

Sales geography
United States (about 48% of sales, nationwide: Northeast, Midwest, South and West), Canada and Mexico (rest of North America), Europe (about 20%), Asia Pacific including China, India, Japan, Australia, New Zealand, Thailand, Indonesia and the Philippines (about 15%), and Latin America, Africa and the Middle East (about 7%)
Historical growth strategy
Mostly organic growth from technical formulation work with food, beverage, cosmetic and pharmaceutical customers, building specialty capabilities such as natural colors over about 15 years and investing in capacity when regulation or customer demand shifts. Supplemented by small bolt-on acquisitions (for example Biolie in 2025) and by pruning lower-margin lines (inks and yogurt fruit preparations in 2020, fragrances in 2021), with a steady dividend paid since 1962.
Chart analysis
A chartist would point to a long-term breakout: after years of range-bound trading, the shares climbed well above their earlier multi-year range, with a 52-week range of roughly $83 to $139. In early October 2026 the stock sat near $128, a few percent below its high, in the middle of a wide short-term rising channel. Momentum readings are mixed, with the longer moving average still above the shorter one and a sell signal from mid-September that has not yet produced follow-through. Near-term support is around $127 and resistance around $130-132; a close above the $139 high would confirm the uptrend, while a break below support would point to a deeper pullback toward the prior consolidation zone.
Competitors

Companies we consider competitors of SXT. Tap a ticker to open our analysis of that company in a new tab.

Circle of competence

We don't have circle of competence information for this company yet.